Editorial

New paradigms for the sequential treatment of severe aortic stenosis: imaging-guided selection of the first intervention paves the way for lifetime management

EuroIntervention 2022;18:e357-e359. DOI: 10.4244/EIJ-E-22-00020

Bernard Prendergast
Bernard P. Prendergast1,2, DM, FRCP; Tiffany Patterson1, PhD, FRCP
1. St Thomas’ Hospital, London, United Kingdom; 2. Cleveland Clinic London, London, United Kingdom
Not so long ago, towards the end of the last century, surgical aortic valve replacement (SAVR) with a mechanical prosthesis combined with lifelong anticoagulation using vitamin K antagonists (requiring regular haematological monitoring and with an attendant risk of bleeding) was the only treatment option for patients with severe aortic stenosis. The mainstream application of bioprosthetic surgical valves in the 1980s and 1990s presented a major breakthrough, allowing older patients at higher risk of bleeding the possibility of surgery without the need for lifelong anticoagulation. These patients were initially deemed unlikely to outlive their valve and the prospect of a second ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Transcatheter or surgical aortic valve replacement in severely obese patients?

Latest news